These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 9044569)

  • 21. Modulation of p75-dependent motor neuron death by a small non-peptidyl mimetic of the neurotrophin loop 1 domain.
    Pehar M; Cassina P; Vargas MR; Xie Y; Beckman JS; Massa SM; Longo FM; Barbeito L
    Eur J Neurosci; 2006 Sep; 24(6):1575-80. PubMed ID: 17004921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maximal and minimal motor nerve conduction velocities in patients with motor neuron diseases: correlation with age of onset and duration of illness.
    Iijima M; Arasaki K; Iwamoto H; Nakanishi T
    Muscle Nerve; 1991 Nov; 14(11):1110-5. PubMed ID: 1745286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular pathogenesis of motor neuron diseases].
    Sobue G
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Feb; 21(1):21-25. PubMed ID: 11400322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Differential diagnosis and atypical subsets of amyotrophic lateral sclerosis].
    Pradat PF; Bruneteau G
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S81-4S90. PubMed ID: 17128093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell therapy and stem cells in animal models of motor neuron disorders.
    Hedlund E; Hefferan MP; Marsala M; Isacson O
    Eur J Neurosci; 2007 Oct; 26(7):1721-37. PubMed ID: 17897390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis.
    Schaefer AM; Sanes JR; Lichtman JW
    J Comp Neurol; 2005 Sep; 490(3):209-19. PubMed ID: 16082680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A molecular genetic approach to amyotrophic lateral sclerosis.
    Siddique T; Hu P; Hentati A; Deng G; Hung WY; McInnis MG; Warren AC; Rimmler J; Antonarakis S; Pericak-Vance MA
    Int J Neurol; 1991-1992; 25-26():60-9. PubMed ID: 11980064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axon guidance proteins: novel therapeutic targets for ALS?
    Schmidt ER; Pasterkamp RJ; van den Berg LH
    Prog Neurobiol; 2009 Aug; 88(4):286-301. PubMed ID: 19523502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetically engineered mouse models of neurodegenerative diseases.
    Wong PC; Cai H; Borchelt DR; Price DL
    Nat Neurosci; 2002 Jul; 5(7):633-9. PubMed ID: 12085093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview of motor neuron disease: classification and nomenclature.
    Bradley WG
    Clin Neurosci; 1995-1996; 3(6):323-6. PubMed ID: 9021252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic disorders of motor neurons.
    Cole N; Siddique T
    Semin Neurol; 1999; 19(4):407-18. PubMed ID: 10716663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons.
    Chou SM; Norris FH
    Muscle Nerve; 1993 Aug; 16(8):864-9. PubMed ID: 8332139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder.
    Vázquez-Costa JF; Arlandis S; Hervas D; Martínez-Cuenca E; Cardona F; Pérez-Tur J; Broseta E; Sevilla T
    J Neurol Sci; 2017 Jul; 378():130-136. PubMed ID: 28566149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALS and other motor neuron diseases.
    Tiryaki E; Horak HA
    Continuum (Minneap Minn); 2014 Oct; 20(5 Peripheral Nervous System Disorders):1185-207. PubMed ID: 25299277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Motoneuron disease.
    Sendtner M
    Handb Exp Pharmacol; 2014; 220():411-41. PubMed ID: 24668481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology.
    Comley LH; Nijssen J; Frost-Nylen J; Hedlund E
    J Comp Neurol; 2016 May; 524(7):1424-42. PubMed ID: 26502195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.
    O'Connor DM; Boulis NM
    Neurosci Lett; 2012 Oct; 527(2):78-84. PubMed ID: 22579818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hereditary motor neuropathies and motor neuron diseases: which is which.
    Hanemann CO; Ludolph AC
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Dec; 3(4):186-9. PubMed ID: 12710507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced EMG techniques in diagnostics of spinal muscular atrophies and motor neuron disease--magnetic stimulation, single fiber EMG and macro EMG.
    Bartousek J; Hlustík P; Grenarová O; Beranová M
    Acta Univ Palacki Olomuc Fac Med; 1993; 136():37-9. PubMed ID: 7887198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship of spinal muscular atrophy to motor neuron disease: investigation of SMN and NAIP gene deletions in sporadic and familial ALS.
    Orrell RW; Habgood JJ; de Belleroche JS; Lane RJ
    J Neurol Sci; 1997 Jan; 145(1):55-61. PubMed ID: 9073029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.